Arkolith/Insider Trading/ADMA/Form 4

Grossman Adam S

President and CEO, DirectorADMA BIOLOGICS, INC. (ADMA) · full profile →Form 4 · filed Feb 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$338K
Net Open-Market Flow
-$338K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 17, 2026Sell(S)6K$16.08$96K2.3M
Feb 17, 2026Sell(S)15K$16.08$241K2.3M
Feb 17, 2026Option exercise(M)15K$5.40$81K2.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Option exercise(M)15K—$0706K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-26-005888) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML